Clinical Trial Update: Intravitreal Bevacizumab for Inflammatory Neovascular Membranes [Phase 3]

View source ↗

Summary

Phase 3 trial of intravitreal bevacizumab for inflammatory neovascular membranes was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multifocal Choroiditis
• Serpiginous Choroiditis
• Vogt-koyanagi-harada Disease

Drugs mentioned

• Bevacizumab (Avastin) (bevacizumab)

Snippet

Sponsor: Asociación para Evitar la Ceguera en México | Conditions: Vogt Koyanagi Harada Disease, Serpiginous Choroiditis | Phase 3 | Status: WITHDRAWN